Pharmaceutical Associates, Inc.
5 drugs in NADAC|5 Generic,0 Brand
Pharmaceutical Associates, Inc. lists 5 NDCs in the CMS NADAC file (5 generic, 0 brand), at an average NADAC of $0.19 per unit, with a week-over-week move of -2.9% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
5
5G / 0B
Avg Price / Unit
$0.1899
$0.02 – $0.69
Avg 7d Change
-2.88%
Across 2 drugs with changes
7d Activity
of 5 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
NYSTATIN market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Polyene Antifungal therapeutic class
Review the broader class where Pharmaceutical Associates, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Pharmaceutical Associates, Inc. make?
Pharmaceutical Associates, Inc. lists 5 NDCs in the CMS NADAC file — 5 generic and 0 brand products.
What is the average price of Pharmaceutical Associates, Inc. drugs?
The average NADAC across Pharmaceutical Associates, Inc.'s portfolio is $0.1899 per unit, ranging from $0.0229 to $0.6863.
What types of drugs does Pharmaceutical Associates, Inc. make?
Pharmaceutical Associates, Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Polyene Antifungal (2), Anti-coagulant (2), Calculi Dissolution Agent (2), Benzodiazepine (1), Histamine-2 Receptor Antagonist (1).
Has Pharmaceutical Associates, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Pharmaceutical Associates, Inc. in the openFDA feed.
How has Pharmaceutical Associates, Inc.'s pricing changed recently?
Over the past 7 days, 0 Pharmaceutical Associates, Inc. products rose and 2 fell, with a portfolio-wide average change of -2.9%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LORAZEPAM 2 MG/ML ORAL CONCENT Lorazepam | $0.6863 per ML | -0.94% |
NYSTATIN 100,000 UNIT/ML SUSP NYSTATIN | $0.1264 per ML | — |
RANITIDINE 15 MG/ML SYRUP RANITIDINE | $0.0579 per ML | — |
NYSTATIN 100,000 UNIT/ML SUSP NYSTATIN | $0.0561 per ML | — |
SOD CITRATE-CITRIC ACID SOLN SODIUM CITRATE and CITRIC ACID MONOHYDRATE | $0.0229 per ML | -4.82% |